(PubMed) Hiltunen JK, Autio KJ, Schonauer MS, Kursu VA, Dieckmann CL, Kastaniotis AJ
How Your Genetics Relate to GLP-1 Pathways PlexusDx's Precision Peptide Genetic Test maps your GIPR, FTO, and MC4R genetic variantsmarkers that influence how quickly your body responds to semaglutide and how intense initial side effects may be
doi:10.1002/14651858.CD009861.pub2 Back SE, McCauley JL, Korte KJ, et al
In May 2026, Innogen announced it will present full Phase IIb results from its ENLIGHT clinical trial at the 2026 American Diabetes Association (ADA) Scientific Sessions
Im hopeful that our findings can be used by the FDA to ensure fair and appropriate advertising by websites selling compounded GLP-1 RAs